Beta© 2026 Adaptrex, LLC
Beta© 2026 Adaptrex, LLC
Federal grant · project grant (b)
Ultrasensitive Multiomic Platform Using Epitope-targeted Dna Methylation Mapping - Candidate Eligibility Statement the Goal of This Diversity Supplement Application Is to Provide Career Development Support for DR. Allison Hickman, a Bioinformatician Who Aspires to (and With Support Could Perform) Leadership Roles in Commercial Science. Women Have Been Under-represented in Science Leadership, Particularly in the Field of Bioinformatics, and This Award Would Formally Address the Issue by Supporting a Truly Talented Individual. DR. Hickman Is a Us Citizen and Full-time Employee at Epicypher Inc., a Small Business Concern (SBC) Eligible to Submit Applications to the National Institutes of Health. Epicypher Was Recently Awarded an Sbir Fast-track Grant From Nhgri [R44 HG011875] That Is Currently in Year One (of Three) and Is Eligible for Diversity Supplement Support. 5.12.2022 DR. Allison Hickman - Diversity Supplement Candidate (research Scientist) Date 5.11.2022 DR. Martis Cowles - Epicypher Signing Official (chief Business Officer) Date
Committed
$2.9 Million
Paid out
$2.5M
87%
Committed, not yet paid
$380.2K
13%
Everything here is this single award's whole record — signed, amended, paid — not a fiscal-year slice. The by-year charts elsewhere split an award across the years it was committed; this page keeps it whole.
Committed is what the government has legally promised on this award so far. Contracts can also carry a ceiling — the maximum if every option is exercised. Unspent ceiling is headroom, not money owed.
The cash actually disbursed against this award. The gap from committed is the disbursement pipeline: promised, not yet cashed.
Each transaction is a signing event — an action that created or changed the award, dated the day it was signed — not a payment. Negative amounts are real: money de-committed at closeout or renegotiation.
One bar, the award’s whole arithmetic: paid out, then committed, not yet paid, then .
Loading…